Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Cohen Joshua B sold 30,464 Amylyx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 10, 2026 · Filed Sep 14, 2026
On Sep 10, 2026, Cohen Joshua B (Director, Co-Chief Executive Officer) sold 30,464 Amylyx Pharmaceuticals, Inc. shares at an average US$32.19 for US$981K, leaving 3,613,123 shares. Filed Sep 14, 2026 (Form 4).
- Sold
- 30,464 shares
- Price
- US$32.19 average (US$32.16 to US$33.15)
- Value
- US$981K
- Holding after
- 3,613,123 shares
- Trading plan
- No
- Role
- Director, Co-Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Sale | 29,545 | US$32.16 | 3,614,042 | Direct |
| Sep 10, 2026 | Common Stock | Sale | 919 | US$33.15 | 3,613,123 | Direct |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Cohen Joshua B
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Cohen Joshua B · Aug 20, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Klee Justin B. · Sep 14, 2026